IDRI Continuing Work. IDRI intends, in part with financial support from Immune Design as described in this Agreement, to continue during the Continuing Work Period to exert reasonable efforts to discover, invent, and characterize (a) *** and/or (b) modifications or other improvements to GLA (other than IDRI FMC Technology).
Appears in 2 contracts
Sources: License Agreement (Immune Design Corp.), License Agreement (Immune Design Corp.)